John B. Moriarty, Jr., Esq., Secretary
John Moriarty is Executive Vice President and General Counsel of Portola Pharmaceuticals and serves as Portola's chief legal officer, responsible for leading all legal, regulatory, governance and compliance initiatives and is a member of Portola's Executive Committee.
Prior to joining Portola, Mr. Moriarty was Executive Vice President and General Counsel of Alexion Pharmaceuticals where he had responsibility for overseeing all global legal matters as well as the global government affairs and corporate communications teams and developing those functions to support an increasing number of initiatives on behalf of patients with rare and devastating disorders in the 50 countries within which Alexion operates. Prior to joining Alexion, Mr. Moriarty was Senior Vice President, General Counsel and Chief Legal Officer at Elan Corporation plc, and served as a member of Elan’s executive management team. In his time at Elan, he was also Senior Vice President of Law, Litigation and Commercial Operations. Prior to that, Mr. Moriarty held several legal leadership positions at Amgen focused on litigation, and led the Amgen legal teams for the company’s commercial oncology, nephrology and hematology businesses. He has also worked as an attorney in the health care practice of a national law firm’s Washington, D.C., and New York offices and was a health care fraud prosecutor in the U.S. Attorney’s Office and the Virginia Attorney General’s Office.
Mr. Moriarty holds a Juris Doctor from the University of Georgia School of Law and a Bachelor of Arts from the University of Virginia.
He serves as Secretary of the AKF Board of Trustees, and is on the Executive, Health Insurance Premium Program (HIPP), Audit and Public Policy Committees.